Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on July 20, 2009, detailing two significant corporate actions. Firstly, Dr. Errol B. De Souza retired from the Board of Directors, effective July 15, 2009. This retirement was stated to be without any disagreement with the company or its management, which is a positive indicator for internal stability. Secondly, and more substantively for investors concerned with corporate governance and shareholder rights, the Board of Directors approved amendments to the company's By-Laws, also effective July 15, 2009. These amendments primarily revise and expand the advance notice requirements for stockholder proposals at annual meetings and for director nominations. This change impacts the timeline for shareholders wishing to submit proposals or nominate directors for the 2010 annual meeting, requiring notice within a specific window in early 2010.
Key Highlights
- 1Dr. Errol B. De Souza retired from the Board of Directors on July 15, 2009.
- 2Dr. De Souza's retirement was not due to any disagreements with the Company or its management.
- 3IDEXX's Board of Directors amended the company's By-Laws, effective July 15, 2009.
- 4The By-Law amendments revise and expand advance notice requirements for stockholder proposals.
- 5The By-Law amendments also revise and expand advance notice requirements for director nominations.
- 6New deadlines are set for director nominations and stockholder proposals for the 2010 annual meeting.
- 7The deadline for Rule 14a-8 proposals for inclusion in proxy materials for the 2010 meeting remains November 26, 2009.